...
机译:CRISPR筛选将WEE1识别为恶性胸膜间皮瘤的标准化疗的组合目标
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Univ Bern Interfac Bioinformat Unit Bern Switzerland;
Univ Bern Inst Pathol Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
Bern Univ Hosp Inselspital Div Gen Thorac Surg Bern Switzerland;
机译:CRISPR筛选将WEE1识别为恶性胸膜间皮瘤的标准化疗的组合目标
机译:Nintedanib与Pemetryexed和Cisplatin联合用于化疗 - 天真患者的晚期恶性胸膜间皮瘤(Lume-Meso):双盲,随机,安慰剂控制第3阶段试验
机译:P2.06-10组合化疗与顺铂,Pemetrexed和Nivolumab用于恶性胸膜间皮瘤:正在进行的试验
机译:可行性试验评估腹膜内光动力学治疗与胸膜切除术/凝固患者患者在恶性胸膜间皮瘤患者中相结合。
机译:恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
机译:甲氨蝶呤联合吉西他滨联合化疗治疗恶性胸膜间皮瘤
机译:CRISPR筛选将WEE1识别为恶性胸膜间皮瘤的标准化疗的组合目标